tpm 02 insulin, page-24

Hey there GC-

Okay lets have a really serious look at the form guide.

I can see our early entries Novartis, CSL, Eli Lilly and Sanofi-Aventis in the mounting yard and looking like very strong contenders. But we need a bigger field for this Great Race for POHs TPM Insulin Cup.

We had better invite another highly regarded favorite- Novo Nordisk to enter (it has the broadest diabetes product portfolio in the industry and is a world leader in diabetes care). Then our Scouts should be talking to GlaxoSmithKlein, Takeda, Bristol Meuers Squibb, Merck & Bayer to pad out the field. This is clearly no "one horse race" for the POH Insulin Cup. Ive locked in my favorite and am hoping he wins by a nose. This Insulin Cup is the Holy Grail for Big Pharma.
KC